Clinical Trials Logo

Clinical Trial Summary

The study will randomized patients to either open or laparoscopic pancreatic surgery. The primary purpose of the study is to determine whether laparoscopic distal pancreatectomy is associated with improved outcomes compared to open distal pancreatectomy.


Clinical Trial Description

Open distal pancreatectomy with or without splenectomy has been commonly employed for the treatment of a variety of pancreatic diseases. Although many general surgical procedures have been increasingly performed laparoscopically or with laparoscopic assistance, until the current decade, laparoscopic pancreatic surgery had not been performed. Surgeons at Indiana University Hospital have safely applied laparoscopic surgery to very select patients with pancreatic disease since 2003. Recently, the outcomes of laparoscopic distal pancreatectomy at Indiana University in combination with multiple other institutions were reviewed and presented at the American Surgical Association Meeting 2008. These data suggest that laparoscopic when compared with open distal pancreatectomy may be associated with lower blood loss (357 vs. 588 cc, p<0.01), fewer complications (40 vs. 57%, p<0.01), and shorter hospital stays (5.9 vs. 9.0 days, p<0.01). Furthermore, the laparoscopic approach was an independent predictor of shorter hospital stays. The main criticism of this retrospective study and similarly designed studies is that there is likely to be a selection bias in patients who undergo laparoscopic distal pancreatectomy which may account for the apparent positive results in favor of laparoscopic distal pancreatectomy. In other words, patient factors, not the operative approach may be more predictive of the outcome. Based on these data, however, laparoscopic distal pancreatectomy appears to be at least as safe as open distal pancreatectomy. Currently, either technique is considered the "standard of care" at Indiana University Hospital as well as several other institutions in the US with expertise in laparoscopic pancreas surgery. To determine whether laparoscopic distal pancreatectomy is truly superior to open distal pancreatectomy in terms of outcomes, we have proposed to randomize patients to laparoscopic vs open distal pancreatectomy. In addition to the randomization, patients will be preoperatively stratified according to whether there is a diagnosis of pancreatic adenocarcinoma, so outcomes in this specific group of patients may be examined. Patients with adenocarcinoma will be randomized separately to insure equal groups in laparoscopic and open distal pancreatectomy groups for this specific diagnosis. Patients with neuroendocrine/islet cell tumors will also be randomized separately to insure equal groups in laparoscopic and open distal pancreatectomy groups for this specific diagnosis. Laparoscopic distal pancreatectomy for adenocarcinoma and neuroendocrine/islet cell tumors is uncommon (e.g., only 9 adenocarcinomas in last 5 years were performed laparoscopically at IU), thus it is clear from the outset that conclusions will be limited about patients with these diagnoses. Although this is being submitted as a single institution study, it will be strongly considered for multi-institutional study design in the near future. Patients will be enrolled on an intention-to-treat manner. Thus, patients who are randomized to laparoscopic distal pancreatectomy who require conversion to open pancreatectomy will still be included in the laparoscopic group in the overall comparative analyses. Subgroup analyses, however, will also be performed excluding this cross-over group. Objectives: Primary: The primary objective is to determine whether laparoscopic distal pancreatectomy is associated with improved outcomes compared to open distal pancreatectomy. Retrospective data suggests that blood loss, overall complication rate and hospital length of stay are positively influenced by the laparoscopic approach. Thus, these specific outcomes will be examined: 1. estimated blood loss 2. overall complication rate 3. hospital length of stay Secondary: 1. to determine whether laparoscopic distal pancreatectomy is safe in patients with pancreatic adenocarcinoma 2. to establish a distal pancreatectomy registry ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00988793
Study type Interventional
Source Indiana University
Contact
Status Withdrawn
Phase N/A
Completion date October 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06208579 - Feasibility and Effectiveness of Augmented Reality Assistance System for Pancreatic Surgery
Completed NCT00414908 - A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Phase 3
Completed NCT00559364 - Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Phase 3
Active, not recruiting NCT04431076 - Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Recruiting NCT05297136 - Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy N/A
Completed NCT03060408 - Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy N/A
Recruiting NCT02230436 - Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial N/A
Completed NCT01929902 - Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
Completed NCT02509910 - Implementation of a GDT Algorithm for Major Surgery Patients N/A
Terminated NCT02617979 - Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement N/A
Recruiting NCT06126601 - Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Terminated NCT02649023 - Deep Venous Thrombosis After Hepatobiliopancreatic Surgery
Completed NCT02623803 - Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies Phase 4
Completed NCT02814812 - Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery N/A
Completed NCT06424431 - Methods of Pancreatic Stump Closure for Distal Pancreatectomy N/A
Active, not recruiting NCT04423731 - Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Recruiting NCT05856474 - Management of Traumatic Pancreas Transection
Not yet recruiting NCT05992857 - Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty N/A
Completed NCT01950845 - Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial N/A
Not yet recruiting NCT04850430 - Gastric Venous Reconstruction After Total Pancreatectomy N/A